[emphasis in original] Yee cited by name Moderna (NASDAQ: MRNA) as an example of a vaccine developer hurt by declining ...

Domski had sought a religious exemption out of her belief that the three COVID-19 vaccines in wide use at the time — by ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Moderna (MRNA – Research Report) today and set a price ...

Recent health news includes the FDA's approval of Johnson & Johnson's heart device, calls for President-elect Trump to honor vaccine pledges for Africa, and the proposed removal of phenylephrine by ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes ...

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...

Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...

Moderna delivered better-than-expected profit and sales in the third quarter after an early start to sales of this season’s ...